Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers
{{output}}
Introduction: Immune checkpoint inhibition (ICI) has proven to be a major breakthrough in hepatobiliary cancers treatment. However, immune-related adverse events (irAEs) remain a major concern. The gut microbiome has been implica... ...
